
UK - Close Ventures leads £2m follow-on funding of Xceleron
Close Ventures has invested £1.5m as part of a £2m follow-on funding round in Xceleron Ltd, a provider of early-stage drug development and assessment services to the biotechnology and pharmaceutical industries. The balance was provided by Foursome Investments, as well as directors and management. This additional investment brings the total investment in Xceleron to over £4m following a £2m funding round provided by the same investors in May 2005. The new capital will fund the company’s expansion in its core UK and US markets.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater